<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK11167" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK11167/" /><meta name="ncbi_pagename" content="16p11.2 Recurrent Microdeletion - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>16p11.2 Recurrent Microdeletion - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="16p11.2 Recurrent Microdeletion" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2015/12/10" /><meta name="citation_author" content="David T Miller" /><meta name="citation_author" content="Wendy Chung" /><meta name="citation_author" content="Ramzi Nasir" /><meta name="citation_author" content="Yiping Shen" /><meta name="citation_author" content="Kyle J Steinman" /><meta name="citation_author" content="Bai-Lin Wu" /><meta name="citation_author" content="Ellen Hanson" /><meta name="citation_pmid" content="20301775" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK11167/" /><meta name="citation_keywords" content="16p11.2 Recurrent Microdeletion" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="16p11.2 Recurrent Microdeletion" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="David T Miller" /><meta name="DC.Contributor" content="Wendy Chung" /><meta name="DC.Contributor" content="Ramzi Nasir" /><meta name="DC.Contributor" content="Yiping Shen" /><meta name="DC.Contributor" content="Kyle J Steinman" /><meta name="DC.Contributor" content="Bai-Lin Wu" /><meta name="DC.Contributor" content="Ellen Hanson" /><meta name="DC.Date" content="2015/12/10" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK11167/" /><meta name="description" content="The 16p11.2 recurrent microdeletion phenotype is characterized by developmental delay, intellectual disability, and/or autism spectrum disorder (ASD). Developmental delays are related to diminished language, cognitive function, and motor impairments. While IQ scores range from mild intellectual disability to normal, those with IQ scores in the average range typically have other developmental issues such as language delay or ASD. Expressive language appears to be more affected than receptive language. Seizures are observed in approximately 20% of individuals with the recurrent microdeletion. Macrocephaly is common, usually becoming apparent by age two years. Chiari malformations/cerebellar ectopia are the most frequently observed structural brain abnormalities. In individuals with the 16p11.2 recurrent microdeletion the frequency of birth defects of all types is slightly increased, with vertebral anomalies appearing to be most frequent." /><meta name="og:title" content="16p11.2 Recurrent Microdeletion" /><meta name="og:type" content="book" /><meta name="og:description" content="The 16p11.2 recurrent microdeletion phenotype is characterized by developmental delay, intellectual disability, and/or autism spectrum disorder (ASD). Developmental delays are related to diminished language, cognitive function, and motor impairments. While IQ scores range from mild intellectual disability to normal, those with IQ scores in the average range typically have other developmental issues such as language delay or ASD. Expressive language appears to be more affected than receptive language. Seizures are observed in approximately 20% of individuals with the recurrent microdeletion. Macrocephaly is common, usually becoming apparent by age two years. Chiari malformations/cerebellar ectopia are the most frequently observed structural brain abnormalities. In individuals with the 16p11.2 recurrent microdeletion the frequency of birth defects of all types is slightly increased, with vertebral anomalies appearing to be most frequent." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK11167/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/del16p11_2/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK11167/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8CFC03E04138910000000002FD010D.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK11167_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK11167_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mdel15q24/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mdel16p12_2/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK11167_"><span class="title" itemprop="name">16p11.2 Recurrent Microdeletion</span></h1><p class="contrib-group"><span itemprop="author">David T Miller</span>, MD, PhD, FACMG, <span itemprop="author">Wendy Chung</span>, MD, PhD, FACMG, <span itemprop="author">Ramzi Nasir</span>, MD, MPH, <span itemprop="author">Yiping Shen</span>, PhD, FACMG, <span itemprop="author">Kyle J Steinman</span>, MD, MAS, <span itemprop="author">Bai-Lin Wu</span>, M Med, PhD, FACMG, and <span itemprop="author">Ellen Hanson</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK11167_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK11167_ai__"><div class="contrib half_rhythm"><span itemprop="author">David T Miller</span>, MD, PhD, FACMG<div class="affiliation small">Division of Genetics and Genomics<br />Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@2rellim.divad" class="oemail">ude.dravrah.snerdlihc@2rellim.divad</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Wendy Chung</span>, MD, PhD, FACMG<div class="affiliation small">Departments of Pediatrics and Medicine<br />Columbia University<br />New York, New York<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.aibmuloc@51ckw" class="oemail">ude.aibmuloc@51ckw</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ramzi Nasir</span>, MD, MPH<div class="affiliation small">Division of Developmental Medicine<br />Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@risan.izmar" class="oemail">ude.dravrah.snerdlihc@risan.izmar</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Yiping Shen</span>, PhD, FACMG<div class="affiliation small">Department of Laboratory Medicine<br />Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@nehs.gnipiy" class="oemail">ude.dravrah.snerdlihc@nehs.gnipiy</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Kyle J Steinman</span>, MD, MAS<div class="affiliation small">Department of Neurology<br />Seattle Children's Hospital / University of Washington<br />Seattle, Washington<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.wu@sjelyk" class="oemail">ude.wu@sjelyk</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Bai-Lin Wu</span>, M Med, PhD, FACMG<div class="affiliation small">Department of Laboratory Medicine<br />Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@uw.nil-iab" class="oemail">ude.dravrah.snerdlihc@uw.nil-iab</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Ellen Hanson</span>, PhD<div class="affiliation small">Division of Developmental Medicine<br />Boston Children's Hospital<br />Boston, Massachusetts<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.dravrah.snerdlihc@nosnah.nelle" class="oemail">ude.dravrah.snerdlihc@nosnah.nelle</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">September 22, 2009</span>; Last Update: <span itemprop="dateModified">December 10, 2015</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="del16p11_2.Summary" itemprop="description"><h2 id="_del16p11_2_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>The 16p11.2 recurrent microdeletion <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> is characterized by developmental delay, intellectual disability, and/or autism spectrum disorder (ASD). Developmental delays are related to diminished language, cognitive function, and motor impairments. While IQ scores range from mild intellectual disability to normal, those with IQ scores in the average range typically have other developmental issues such as language delay or ASD. Expressive language appears to be more affected than receptive language. Seizures are observed in approximately 20% of individuals with the recurrent microdeletion. Macrocephaly is common, usually becoming apparent by age two years. Chiari malformations/cerebellar ectopia are the most frequently observed structural brain abnormalities. In individuals with the 16p11.2 recurrent microdeletion the frequency of birth defects of all types is slightly increased, with vertebral anomalies appearing to be most frequent.</p></div><div><h4 class="inline">Diagnosis/testing.</h4><p>The 16p11.2 microdeletion is defined as the recurrent ~593-kb <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at the approximate position of 29.6-30.2 Mb in the reference genome (GRCh37/hg19). The microdeletion is identified by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing that determines copy number of sequences, such as <a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA). This deletion cannot be detected by routine analysis of G-banded chromosomes or other conventional <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> banding techniques. While <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis is not appropriate for identification of the deletion in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>, it may be used to test relatives of a proband who is known to have the deletion.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations:</i> Treatment should be targeted to the specific deficits identified. Full developmental assessment, including neuropsychological testing by a clinical psychologist, is strongly suggested to establish neurodevelopmental needs and treatment recommendations. Refer to a neurologist if seizures are suspected. Because of the high risk of obesity beginning in adolescence, encourage healthy eating habits with attention to portion size and an active lifestyle from a young age. Routine management of vertebral anomalies.</p><p><i>Surveillance:</i> Routine surveillance, screening, and management based on American Academy of Pediatrics published guidelines on developmental delays and ASD. Maintain a low index of suspicion for possible seizures (which may manifest as, e.g., abnormal movements, staring spells). Obtain brain MRI if manifestations of Chiari I malformation appear. Periodic reevaluation by a medical geneticist to apprise the family of new developments and/or recommendations and facilitate long-term monitoring for emerging medical and/or mental health concerns.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>16p11.2 microdeletion is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. The <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> often has a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>; however, the deletion can also be transmitted from a parent to a child. Prenatal diagnosis for at-risk pregnancies requires prior identification of the deletion in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member. Interpretation of results from prenatal testing is challenging given the inherent difficulty in accurately predicting the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div></div><div id="del16p11_2.Diagnosis"><h2 id="_del16p11_2_Diagnosis_">Diagnosis</h2><div id="del16p11_2.Suggestive_Findings"><h3>Suggestive Findings</h3><p>The 16p11.2 recurrent microdeletion <b>should be suspected</b> in individuals with the following clinical findings:</p><ul><li class="half_rhythm"><div>Delayed language development (with expressive language typically more affected than receptive language) and abnormal speech articulation</div></li><li class="half_rhythm"><div>Learning difficulties/intellectual disability</div></li><li class="half_rhythm"><div>Social impairments with or without a diagnosis of autism spectrum disorder (ASD)</div></li><li class="half_rhythm"><div>Macrocephaly</div></li><li class="half_rhythm"><div>Chiari I/cerebellar tonsillar ectopia</div></li><li class="half_rhythm"><div>Seizures/epilepsy</div></li><li class="half_rhythm"><div>Vertebral anomalies</div></li><li class="half_rhythm"><div>Obesity starting in adolescence, and in the setting of developmental delay</div></li></ul></div><div id="del16p11_2.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of the 16p11.2 recurrent microdeletion is established by demonstration of <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of the ~593-kb <a class="def" href="/books/n/gene/glossary/def-item/critical-region/">critical region</a> at the approximate position of 29.6-30.2 Mb in the reference genome (GRCh37/hg19) (see <a class="figpopup" href="/books/NBK11167/table/del16p11_2.T.genomic_testing_used_for_th/?report=objectonly" target="object" rid-figpopup="figdel16p112Tgenomictestingusedforth" rid-ob="figobdel16p112Tgenomictestingusedforth">Table 1</a> and <a href="#del16p11_2.Molecular_Genetics">Molecular Genetics</a>).</p><p>Of note, an adjacent (distal) recurrent 16p11.2 microdeletion (GRCh37/hg19 chr16:28.8-29.0 Mb) which is also associated with variable features is not discussed further as this <i>GeneReview</i> addresses the 29.6-30.2-Mb <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> only.</p><p><b>Molecular methods</b> that determine the copy number of sequences can include <b><a class="def" href="/books/n/gene/glossary/def-item/chromosomal-microarray/">chromosomal microarray</a> (CMA)</b> or <b>targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis</b> by <b>fluorescence in situ hybridization (<a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>).</b> Note: The 16p11.2 microdeletion cannot be identified by routine analysis of G-banded chromosomes or other conventional <a class="def" href="/books/n/gene/glossary/def-item/cytogenetic/">cytogenetic</a> banding techniques.</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Chromosomal microarray (CMA)</b> using oligonucleotide arrays or SNP <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> arrays can detect the <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. The ability to size the deletion depends on the type of microarray used and the density of probes in the 16p11.2 region.</div><div class="half_rhythm">Note: (1) Most individuals with 16p11.2 recurrent microdeletion are identified by CMA performed in the context of evaluation of developmental delay, intellectual disability, or ASD. (2) Prior to 2008 many CMA platforms did not include coverage for this region and thus may not have detected this <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis.</b> <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a> analysis, <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a> (qPCR), multiplex ligation-dependent probe amplification (MLPA), or other targeted quantitative methods may be used to test relatives of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> known to have the 16p11.2 recurrent microdeletion.</div><div class="half_rhythm">Note: (1) Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> testing is not appropriate for an individual in whom the 16p11.2 recurrent microdeletion was not detected by CMA designed to target this region. (2) It is not possible to size the deletion routinely by use of targeted methods.</div></li></ul><div id="del16p11_2.T.genomic_testing_used_for_th" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Genomic Testing Used for the 16p11.2 Recurrent Microdeletion</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11167/table/del16p11_2.T.genomic_testing_used_for_th/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__del16p11_2.T.genomic_testing_used_for_th_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_1" style="text-align:left;vertical-align:middle;">Deletion&#x000a0;<sup>1</sup></th><th id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_2" rowspan="2" scope="col" colspan="1" headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_2" style="text-align:left;vertical-align:middle;">ISCA ID&#x000a0;<sup>2</sup></th><th id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_3" rowspan="2" scope="col" colspan="1" headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_3" style="text-align:left;vertical-align:middle;">Region Location&#x000a0;<sup>3,&#x000a0;4</sup></th><th id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_4" rowspan="2" scope="col" colspan="1" headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_4" style="text-align:left;vertical-align:middle;">Method</th><th id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5" colspan="2" scope="colgroup" rowspan="1" style="text-align:center;vertical-align:middle;">Sensitivity</th></tr><tr><th headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5" id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Proband</th><th headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5" id="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">At-risk family members</th></tr></thead><tbody><tr><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;">~593-kb <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> at 16p11.2</td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_2" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/projects/dbvar/clingen/clingen_region.cgi?id=ISCA-37400" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ISCA-37400</a></td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_3" rowspan="2" colspan="1" style="text-align:left;vertical-align:middle;">GRCh37/hg19 chr16: 29,606,852-30,199,855</td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_4" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Chromosomal microarray&#x000a0;<sup>5</sup></td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5 hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5 hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%</td></tr><tr><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_4" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis&#x000a0;<sup>6</sup></td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5 hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Not applicable&#x000a0;<sup>6</sup></td><td headers="hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_1_5 hd_h_del16p11_2.T.genomic_testing_used_for_th_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">100%&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="del16p11_2.TF.1.1"><p class="no_margin">See <a href="#del16p11_2.Molecular_Genetics">Molecular Genetics</a> for details of the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>.</p></div></dd><dt>2. </dt><dd><div id="del16p11_2.TF.1.2"><p class="no_margin">Standardized clinical annotation and interpretation for <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> variants from the Clinical Genome Resource (<a href="http://www.clinicalgenome.org/about/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinGen</a>) project (formerly the International Standards for Cytogenomic Arrays (ISCA) Consortium)</p></div></dd><dt>3. </dt><dd><div id="del16p11_2.TF.1.3"><p class="no_margin">Genomic coordinates represent the minimum <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> size associated with the recurrent 16p11.2 deletion as designated by ClinGen. Deletion coordinates may vary slightly based on array design used by the testing laboratory. Please note that the size of the deletion as calculated from these <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> positions may differ from the expected deletion size due to the presence of segmental duplications near breakpoints. The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of significantly larger or smaller deletions within this region may be clinically distinct from the recurrent 16p11.2 deletion (see <a href="#del16p11_2.Genetically_Related_Allelic_D">Genetically Related Disorders</a>).</p></div></dd><dt>4. </dt><dd><div id="del16p11_2.TF.1.4"><p class="no_margin">See <a href="#del16p11_2.Molecular_Genetics">Molecular Genetics</a>, <b>Genes typically included in this region</b>.</p></div></dd><dt>5. </dt><dd><div id="del16p11_2.TF.1.5"><p class="no_margin">Chromosome microarray analysis (CMA) using oligonucleotide arrays or SNP <a class="def" href="/books/n/gene/glossary/def-item/genotyping/">genotyping</a> arrays. CMA designs in current clinical use target the 16p11.2 region. Note: The 16p11.2 recurrent microdeletion may not have been detectable by older oligonucleotide or BAC platforms.</p></div></dd><dt>6. </dt><dd><div id="del16p11_2.TF.1.6"><p class="no_margin">Targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis methods can include <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a> (qPCR), and multiplex ligation-dependent probe amplification (MLPA) as well as other targeted quantitative methods. Targeted deletion analysis is not appropriate for an individual in whom the 16q11.2 recurrent microdeletion was not detected by CMA designed to target this region.</p></div></dd></dl></div></div></div><p><b>Evaluating at-risk relatives.</b> <a class="def" href="/books/n/gene/glossary/def-item/fish/">FISH</a>, qPCR, or other quantitative methods of targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> analysis can be used to identify the 16q11.2 recurrent microdeletion in at-risk relatives of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>. Testing parental samples is important in determining <a class="def" href="/books/n/gene/glossary/def-item/recurrence-risk/">recurrence risk</a> (see <a href="#del16p11_2.Related_Genetic_Counseling_Is">Genetic Counseling</a>).</p></div></div><div id="del16p11_2.Clinical_Characteristics"><h2 id="_del16p11_2_Clinical_Characteristics_">Clinical Characteristics</h2><div id="del16p11_2.Clinical_Description"><h3>Clinical Description</h3><p>The 16p11.2 recurrent microdeletion was first reported in individuals with autism spectrum disorder (ASD) [<a class="bk_pop" href="#del16p11_2.REF.kumar.2008.628">Kumar et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.marshall.2008.477">Marshall et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al 2008</a>]. Prior to that, this 16p11.2 recurrent microdeletion was reported as a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/copy-number-variant/">copy number variant</a> in an individual with Asperger disorder [<a class="bk_pop" href="#del16p11_2.REF.sebat.2007.445">Sebat et al 2007</a>] and in two monozygotic twins with seizures, mild intellectual disability, and aortic valve abnormalities [<a class="bk_pop" href="#del16p11_2.REF.ghebranious.2007.1462">Ghebranious et al 2007</a>].</p><p>Clinical follow-up data from adults suggests that the greatest medical challenges are obesity and related comorbidities that can be exacerbated by medications used to treat behavioral and psychiatric problems.</p><p>Males and females are equally <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a>.</p><p><b>Cognitive impairment.</b> On average, the IQ of individuals with the 16p11.2 recurrent microdeletion is approximately 2 SD lower than other family members without the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>. Average IQ was 82.7, representing a 26.8-point (1.8 SD) shift downward compared to the full scale IQ average of 109.5 of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> controls [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</p><p><b>Other developmental delay.</b> Most, if not all, individuals with the 16p11.2 recurrent microdeletion experience some degree of developmental delay, although the severity varies. Developmental coordination (motor) disorder was one of the most common diagnoses in individuals with the 16p11.2 recurrent microdeletion, followed by phonologic processing disorder, language disorders, and ASD [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</p><p>In the authors' clinical experience, most individuals with the 16p11.2 recurrent microdeletion have been ascertained through genetic testing performed in the evaluation of developmental delay, intellectual disability, or ASD. Although developmental delays in this population are more related to diminished language and cognitive function, they can also involve problems with gross and fine motor skills.</p><p><b>Language delay.</b> About 70% of individuals with 16p11.2 recurrent microdeletion have one or more speech/language-related diagnoses. Overall, expressive language appears to be more affected than receptive language and phonologic (articulation) issues are the most common diagnosis given [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</p><p>Children do acquire verbal skills but have significant issues with verbal communication including apraxia for the first five years of life.</p><p>It is speculated that these delays in speech and language development may contribute to behavior problems.</p><p><b>Autistic features.</b> Individuals with the 16p11.2 recurrent microdeletion identified in the earliest reported research studies were ascertained primarily through cohorts of individuals with an ASD. Although not all individuals with the 16p11.2 recurrent microdeletion meet diagnostic criteria for ASD, almost all have some behavioral traits shared with ASD including insistence on sameness, reduced scope of interest, repetitive behaviors, and problems with social communication [<a class="bk_pop" href="#del16p11_2.REF.zufferey.2012.660">Zufferey et al 2012</a>, <a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>, <a class="bk_pop" href="#del16p11_2.REF.morenodeluca.2015.119">Moreno-De-Luca et al 2015</a>].</p><p>Based on current literature reports, ASD is diagnosed in approximately 20% of individuals with the 16p11.2 microdeletion (i.e, with much greater frequency than in the general population, in which ASD is diagnosed in ~1:68 children).</p><p>In a study by <a class="bk_pop" href="#del16p11_2.REF.hanson.2010.649">Hanson et al [2010]</a>, 11 individuals with the 16p11.2 recurrent microdeletion were evaluated for ASD using detailed measures including the Autism Diagnostic Observation Schedule and the Autism Diagnostic Interview: three of the 11 met full criteria for ASD (i.e., cutoffs on both measures); six had findings of ASD but did not meet full criteria; and two did not meet criteria for ASD. In addition, all 11 had some level of restricted or repetitive behavior patterns or interests either currently or in the past [<a class="bk_pop" href="#del16p11_2.REF.gault.2003.39">Gault et al 2003</a>].</p><p>More recently <a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al [2015]</a> assessed 85 individuals with the 16p11.2 recurrent microdeletion with the detailed measures reported above and found that 24% had ASD. The majority of individuals with the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> who did not meet full criteria for ASD had significantly higher rates of autism-related characteristics (e.g., social and behavioral difficulties and repetitive and stereotyped behaviors) when compared to family members who did not have the deletion.</p><p><b>Psychiatric disease and behavioral issues.</b>
<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al [2015]</a> reported that 93% of individuals with the 16p11.2 microdeletion had at least one psychiatric diagnosis, compared to 21% of <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> controls. The mean number of diagnoses in family members who did not have the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> was 0.3; individuals with the deletion had an average of 2.9 diagnoses. These differences persisted after controlling for having ASD.</p><p>Individuals with 16p11.2 microdeletion were found to have significantly higher levels and numbers of behavioral issues than <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> controls [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</p><p><a class="bk_pop" href="#del16p11_2.REF.hanson.2010.649">Hanson et al [2010]</a> did not find a link to ADHD although affective problems, somatic issues, and anxiety were commonly reported.</p><p><b>Neurologic issues</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Seizures</b> are seen in about 20% of individuals with the 16p11.2 recurrent microdeletion. In a case report, one <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual had EEG abnormalities without overt seizures [<a class="bk_pop" href="#del16p11_2.REF.rosenfeld.2010.26">Rosenfeld et al 2010</a>]. Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>PRRT2</i> pathogenic variants (which cause paroxysmal kinesigenic dyskinesia; see following) also cause benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy and infantile convulsions with choreoathetosis syndrome [<a class="bk_pop" href="#del16p11_2.REF.heron.2012.152">Heron et al 2012</a>], both of which have been reported in a number of individuals with the 16p11.2 recurrent microdeletion.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Paroxysmal kinesigenic dyskinesia</b> has been observed in a number of individuals with the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> [<a class="bk_pop" href="#del16p11_2.REF.termsarasab.2014.274">Termsarasab et al 2014</a>]. Onset of movement-induced choreoathetosis and/or dystonia begins between ages six and 15 years with increasing frequency of paroxysms with age. Of note, <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> pathogenic variants in <i>PRRT2</i>, located at 16p11.2, have been identified as a cause of <a href="/books/n/gene/prrt2-parox/">autosomal dominant paroxysmal kinesigenic dyskinesia</a> [<a class="bk_pop" href="#del16p11_2.REF.chen.2011.1252">Chen et al 2011</a>, <a class="bk_pop" href="#del16p11_2.REF.wang.2011.3493">Wang et al 2011</a>, <a class="bk_pop" href="#del16p11_2.REF.lee.2012.2">Lee et al 2012</a>, <a class="bk_pop" href="#del16p11_2.REF.li.2012.76">Li et al 2012</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Handedness.</b> Of 75 of individuals with the 16p11.2 microdeletion, 19% had left hand dominance and 29% had mixed dominance compared to 3% and 11%, respectively, of family members without the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Neuroimaging findings</b> are mostly nonrecurrent abnormalities such as arachnoid cyst [<a class="bk_pop" href="#del16p11_2.REF.bijlsma.2009.77">Bijlsma et al 2009</a>], prominent extra-axial CSF spaces and ventricles [<a class="bk_pop" href="#del16p11_2.REF.shinawi.2010.332">Shinawi et al 2010</a>], mega cisterna magna, and cavernous malformation [<a class="bk_pop" href="#del16p11_2.REF.rosenfeld.2010.26">Rosenfeld et al 2010</a>].</div><div class="half_rhythm">The most common recurrent structural brain abnormalities are posterior fossa and/or craniocervical junction-related abnormalities (e.g., Chiari I malformation, cerebellar tonsillar ectopia, platybasia) [<a class="bk_pop" href="#del16p11_2.REF.zufferey.2012.660">Zufferey et al 2012</a>]. In one case report, two persons with 16p11.2 microdeletion were reported to have syringomyelia (accompanied by a Chiari I malformation in one) [<a class="bk_pop" href="#del16p11_2.REF.schaaf.2011.152">Schaaf et al 2011</a>].</div><div class="half_rhythm">Quantitative structural MRI analysis has shown a pervasive increase in volume throughout the brain, with white matter and thalami being the most dramatically affected [<a class="bk_pop" href="#del16p11_2.REF.qureshi.2014.11199">Qureshi et al 2014</a>].</div></li></ul><p><b>Obesity</b>. The 16p11.2 recurrent microdeletion is a predisposing factor for overweight (defined as sex-specific BMI for age 85-95<sup>th</sup> centile) and obesity (defined as sex-specific BMI for age &#x0003e;95<sup>th</sup> centile).</p><p>Overall, several studies show that obesity is a feature of 16p11.2 microdeletion and that the prevalence of overweight and obesity in individuals with 16p11.2 microdeletion is higher than in the general population [<a class="bk_pop" href="#del16p11_2.REF.ghebranious.2007.1462">Ghebranious et al 2007</a>, <a class="bk_pop" href="#del16p11_2.REF.bijlsma.2009.77">Bijlsma et al 2009</a>, <a class="bk_pop" href="#del16p11_2.REF.bochukova.2010.666">Bochukova et al 2010</a>, <a class="bk_pop" href="#del16p11_2.REF.fernandez.2010.195">Fernandez et al 2010</a>, <a class="bk_pop" href="#del16p11_2.REF.shinawi.2010.332">Shinawi et al 2010</a>, <a class="bk_pop" href="#del16p11_2.REF.walters.2010.671">Walters et al 2010</a>, <a class="bk_pop" href="#del16p11_2.REF.jacquemont.2011.97">Jacquemont et al 2011</a>, <a class="bk_pop" href="#del16p11_2.REF.gill.2014.2625">Gill et al 2014</a>]. Longitudinal studies show that the weight increase starts about age nine years and becomes increasingly problematic into adulthood, especially with use of certain medications used to treat problematic behaviors.</p><p><b>Cardiac malformations and disease associations.</b> Most individuals in whom the diagnosis of 16p11.2 microdeletion is confirmed have not had diagnostic cardiac imaging; however, limited clinical reports suggest that the incidence of cardiac malformations is slightly increased. Congenital heart disease was identified in 6% of 233 individuals with the 16p11.2 recurrent microdeletion [<a class="bk_pop" href="#del16p11_2.REF.zufferey.2012.660">Zufferey et al 2012</a>].</p><p><b>Other medical issues.</b> Although consistent patterns of other medical problems are not observed, the following have been reported in individuals with the 16p11.2 recurrent microdeletion:</p><ul><li class="half_rhythm"><div>Height is slightly below average for individuals who are not overweight and may be average for individuals who are overweight.</div></li><li class="half_rhythm"><div>Vertebral anomalies (often associated with scoliosis) were observed in 21% of 233 individuals with the microdeletion [<a class="bk_pop" href="#del16p11_2.REF.zufferey.2012.660">Zufferey et al 2012</a>].</div></li><li class="half_rhythm"><div>Macrocephaly is frequently observed, usually becomes apparent by age two years, and is usually not secondary to hydrocephalus.</div></li><li class="half_rhythm"><div>Craniosynostosis was observed in 2% of 233 individuals [<a class="bk_pop" href="#del16p11_2.REF.zufferey.2012.660">Zufferey et al 2012</a>].</div></li><li class="half_rhythm"><div>Hearing impairment (sensorineural and conductive hearing loss) is seen in up to 11% of individuals.</div></li><li class="half_rhythm"><div>A characteristic pattern of <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features that would facilitate a clinical diagnosis is not observed in individuals with the16p11.2 recurrent microdeletion. However, several studies have reported on various dysmorphic features [<a class="bk_pop" href="#del16p11_2.REF.bijlsma.2009.77">Bijlsma et al 2009</a>, <a class="bk_pop" href="#del16p11_2.REF.rosenfeld.2010.26">Rosenfeld et al 2010</a>, <a class="bk_pop" href="#del16p11_2.REF.shinawi.2010.332">Shinawi et al 2010</a>].</div></li><li class="half_rhythm"><div>Severe combined immunodeficiency (SCID) was reported in one individual with 16p11.2 microdeletion on one <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> 16 and a <a class="def" href="/books/n/gene/glossary/def-item/single-nucleotide-variant/">single-nucleotide variant</a> in <i>CORO1A</i> on the other chromosome 16 [<a class="bk_pop" href="#del16p11_2.REF.shiow.2009.24">Shiow et al 2009</a>].</div></li></ul></div><div id="del16p11_2.GenotypePhenotype_Correlation"><h3>Genotype-Phenotype Correlations</h3><p>No <a class="def" href="/books/n/gene/glossary/def-item/genotype-phenotype-correlations/">genotype-phenotype correlations</a> have been observed.</p></div><div id="del16p11_2.Prevalence"><h3>Prevalence</h3><p>Estimates of prevalence vary.</p><p>In one population of 299 individuals with autism and 18,834 control samples, three individuals in each category had 16p11.2 microdeletion, giving a population prevalence of approximately 3:10,000 [<a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al 2008</a>]. That number is supported by more recent data showing 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> in approximately 3.5 of 10,000 individuals from a larger, but overlapping, cohort of more than 76,000 Icelandic individuals [<a class="bk_pop" href="#del16p11_2.REF.stefansson.2014.361">Stefansson et al 2014</a>]. It should be noted that "controls" in that study may have had other diagnoses besides autism. Thus, some degree of neurodevelopmental disability in those individuals cannot be ruled out.</p><p>16p11.2 recurrent microdeletion was identified in seven of 1,105 children (0.7%) with unexplained intellectual disability but no history of autism [<a class="bk_pop" href="#del16p11_2.REF.mefford.2009.1579">Mefford et al 2009</a>]. Similar genetic testing of 4,284 individuals with intellectual disability or multiple <a class="def" href="/books/n/gene/glossary/def-item/congenital/">congenital</a> anomalies detected 22 (14 index cases and 8 family members) with the recurrent microdeletion of 16p11.2 [<a class="bk_pop" href="#del16p11_2.REF.bijlsma.2009.77">Bijlsma et al 2009</a>]. Individuals identified in these reports did not have a recognizable clinical <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p><p>Data drawing on the large ClinGen database of more than 15,000 cases tested in clinical labs demonstrates that the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> is the second most commonly identified microdeletion, occurring in one of every 235 cases tested [<a class="bk_pop" href="#del16p11_2.REF.kaminsky.2011.777">Kaminsky et al 2011</a>].</p></div></div><div id="del16p11_2.Genetically_Related_Allelic_D"><h2 id="_del16p11_2_Genetically_Related_Allelic_D_">Genetically Related (Allelic) Disorders</h2><p><b>16p11.2 microduplication.</b> Reciprocal ~593-kb <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> of 16p11.2 has been reported in individuals with developmental delays and/or ASD [<a class="bk_pop" href="#del16p11_2.REF.kumar.2008.628">Kumar et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.marshall.2008.477">Marshall et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al 2008</a>]. In the study by <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al [2008]</a>, 16p11.2 microduplication was found in two non-autistic control individuals with bipolar disorder. The reciprocal duplication has also been reported in at least two cases of childhood-onset schizophrenia [<a class="bk_pop" href="#del16p11_2.REF.walsh.2008.539">Walsh et al 2008</a>]. Microduplication of 16p11.2 has been shown to confer an increased risk for schizophrenia in two large cohorts [<a class="bk_pop" href="#del16p11_2.REF.mccarthy.2009.1223">McCarthy et al 2009</a>]. The microduplication was associated with a 14.5-fold increased risk of schizophrenia.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the 16p11.2 recurrent microduplication shows more variability than the phenotype of the 16p11.2 recurrent microdeletion; however, most individuals with the 16p11.2 recurrent microduplication are identified by CMA performed in the evaluation of developmental delay, intellectual disability, or ASD, conferring an ascertainment bias that makes the phenotype associated with 16p11.2 microduplication difficult to establish.</p><ul><li class="half_rhythm"><div>Greater variance is seen in the IQ of individuals with the 16p11.2 recurrent microduplication than in those with the recurrent microdeletion: on average, probands with the <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> ascertained based on clinical findings have a full scale IQ (FSIQ) approximately 2 SD lower than predicted; in contrast, individuals with the recurrent duplication not ascertained based on clinical findings have a FSIQ approximately1 SD lower than predicted.</div></li><li class="half_rhythm"><div>Persons with 16p11.2 recurrent microduplication do not have characteristic <a class="def" href="/books/n/gene/glossary/def-item/dysmorphic/">dysmorphic</a> features that would facilitate a clinical diagnosis.</div></li><li class="half_rhythm"><div>The prevalence of seizures and problems with growth and short stature is greater among probands with the 16p11.2 recurrent <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> than in the general population.</div></li><li class="half_rhythm"><div>In addition, recurrent microduplication of 16p11.2 is associated with underweight and lower body mass index (BMI). The reciprocal impact of both 16p11.2 recurrent microdeletion and <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> indicate that severe obesity (<a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a>) and being underweight (duplication) could have mirror etiologies, possibly through contrasting effects on energy balance [<a class="bk_pop" href="#del16p11_2.REF.jacquemont.2011.97">Jacquemont et al 2011</a>].</div></li></ul><p>Whereas 16p11.2 recurrent microdeletions are often <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, a larger proportion of recurrent microduplications are inherited. Parents with a 16p11.2 recurrent microduplication may not have a history of developmental delay, ID, or ASD but may have more subtle neurobehavioral manifestations.</p><p><b>16p11.2-p12.2 microdeletion.</b> At least two patients with much larger deletions that include the recurrent 16p11.2 microdeletion region have been described [<a class="bk_pop" href="#del16p11_2.REF.ballif.2007.1071">Ballif et al 2007</a>, <a class="bk_pop" href="#del16p11_2.REF.battaglia.2009.1200">Battaglia et al 2009</a>]. In both patients, the <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> was larger than 8 Mb, causing a more severe <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>.</p></div><div id="del16p11_2.Differential_Diagnosis"><h2 id="_del16p11_2_Differential_Diagnosis_">Differential Diagnosis</h2><p>The differential diagnosis is broad, including any cause of developmental delay and/or autism spectrum disorder without obvious distinguishing clinical features.</p></div><div id="del16p11_2.Management"><h2 id="_del16p11_2_Management_">Management</h2><div id="del16p11_2.Evaluations_Following_Initial"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with the 16p11.2 recurrent microdeletion, the following are recommended:</p><ul><li class="half_rhythm"><div>Routine clinical examination, including dysmorphology examination and broad review of all organ systems</div></li><li class="half_rhythm"><div>Measurement of height and weight</div></li><li class="half_rhythm"><div>Evaluate for hypertension and diabetes in patients who are overweight or obese</div></li><li class="half_rhythm"><div>Developmental assessment with cognitive and behavioral testing, including neuropsychological testing by a clinical psychologist</div></li><li class="half_rhythm"><div>Consultation with a neurologist (with possible EEG and MRI) if history suggests possible seizures</div></li><li class="half_rhythm"><div>Consideration of brain MRI for headache (especially occipital), neck pain, oropharyngeal dysfunction, or other manifestations of brain stem dysfunction</div></li><li class="half_rhythm"><div>Diagnostic radiograph of the spine to evaluate for vertebral anomalies/scoliosis</div></li><li class="half_rhythm"><div>Consideration of evaluation and echocardiogram by a cardiologist if a heart murmur is detected</div></li><li class="half_rhythm"><div>Audiologic testing</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="del16p11_2.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p>Manifestations of the 16p11.2 recurrent microdeletion are variable, and treatment should be targeted to the specific findings identified.</p><p>Early diagnosis and provision of therapies facilitate the best outcome. Referral to other appropriate medical specialists (e.g., a developmental/behavioral pediatrician, pediatric neurologist, and/or clinical geneticist) is recommended based on specific symptoms or signs.</p><p><b>Neurodevelopmental disabilities including autism spectrum disorder (ASD).</b> Interventions may include speech and language therapy, occupational therapy, and physical therapy. Because of the high incidence of expressive language delays, speech therapy and augmentative and assistive means of communication should be considered early.</p><p>Guidelines for management of individuals with ASD are available from the American Academy of Pediatrics [<a class="bk_pop" href="#del16p11_2.REF.myers.2007">Myers et al 2007</a>] (<a href="http://pediatrics.aappublications.org/content/120/5/1162.full.pdf+html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">full text</a>).</p><p><b>Seizures.</b> Choice of antiepileptic medication is guided by patient age, seizure type, EEG and imaging findings, side effect profiles, and response to treatment. No specific antiepileptic medications have been identified to be most effective.</p><p><b>Paroxysmal kinesigenic dyskinesia</b> is responsive to low doses of carbamazepine and phenytoin.</p><p><b>Obesity and overweight.</b> It is important to initiate weight management and nutrition counseling in young children before excessive weight gain begins. Control food intake with normal portion sizes and limitation of food intake between meals. Maintain an active lifestyle. Increased calories are specifically ingested in the absence of hunger and suggest that close supervision of portion size and meal times can be beneficial.</p><p><b>Chiari I malformation or syringomyelia</b>. Brain and spine MRI are indicated for new or progressive symptoms suggestive of a Chiari I malformation or syringomyelia, including sleep apnea, dysarthria, dysphagia, gait disturbance, and scoliosis.</p></div><div id="del16p11_2.Surveillance"><h3>Surveillance</h3><p>Routine developmental surveillance and screening are recommended because of the increased incidence of developmental delay, intellectual disability, and autism. See the American Academy of Pediatrics guidelines on surveillance and screening to identify patients with developmental disorders in general [<a class="bk_pop" href="#del16p11_2.REF.council_on_children_with_disabilities.2006.405">Council on Children with Disabilities 2006</a>] and autism in particular [<a class="bk_pop" href="#del16p11_2.REF.johnson.2007">Johnson et al 2007</a>] and recommendations for management of children with ASD [<a class="bk_pop" href="#del16p11_2.REF.myers.2007">Myers et al 2007</a>] (<a href="#del16p11_2.References">Published Guidelines / Consensus Statements</a>).</p><p>Surveillance should include the following:</p><ul><li class="half_rhythm"><div>Monitoring of height, weight, and BMI</div></li><li class="half_rhythm"><div>Monitoring for abnormal movements, staring spells, or other events of concern for possible seizures</div></li><li class="half_rhythm"><div>Monitoring for headache (especially occipital), neck pain, and other symptoms of brain stem or spinal cord dysfunction that could indicate Chiari malformations/cerebellar ectopia, and neurologic consultation and brain MRI if indicated</div></li><li class="half_rhythm"><div>Clinical screening for scoliosis until the age of skeletal maturity</div></li><li class="half_rhythm"><div>Annual evaluation and monitoring of hearing in first three years of life</div></li><li class="half_rhythm"><div>Periodic reevaluation by a clinical geneticist to apprise the family of new developments and/or recommendations and facilitate long-term monitoring for emerging medical or mental health concerns</div></li></ul></div><div id="del16p11_2.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Some medications used to treat behavioral problems (e.g., clozapine, olanzapine) may lead to excessive weight gain. When possible, use medications that are not associated with weight gain.</p></div><div id="del16p11_2.Evaluation_of_Relatives_at_Ri"><h3>Evaluation of Relatives at Risk</h3><p>See <a href="#del16p11_2.Related_Genetic_Counseling_Is">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="del16p11_2.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="del16p11_2.Genetic_Counseling"><h2 id="_del16p11_2_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="del16p11_2.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>16p11.2 recurrent microdeletion is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. In the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> the recurrent microdeletion is often <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>; however, the microdeletion can also be transmitted from a parent to a child.</p></div><div id="del16p11_2.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div class="half_rhythm">The parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with the 16p11.2 recurrent microdeletion are generally unaffected.</div></li><li class="half_rhythm"><div class="half_rhythm">In approximately 80% of reported probands the 16p11.2 recurrent microdeletion is <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>.</div></li><li class="half_rhythm"><div class="half_rhythm">Evaluation of the parents by <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing that will detect the 16p11.2 recurrent microdeletion present in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is recommended. The 16p11.2 recurrent microdeletion has been detected in mildly <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and unaffected parents.</div></li><li class="half_rhythm"><div class="half_rhythm">When the microdeletion is not <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a>, a parent may have (a) the same molecular finding, (b) <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a>, or (c) low-level <a class="def" href="/books/n/gene/glossary/def-item/somatic-mosaicism/">somatic mosaicism</a> that also includes the germline. (Note: Balanced <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> rearrangement as a cause of the 16p11.2 recurrent microdeletion in a parent of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> child has not been reported to date.)</div><div class="half_rhythm">Rarely, <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> is present in a parent in whom <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing has not identified the 16p11.2 recurrent microdeletion. <a class="bk_pop" href="#del16p11_2.REF.kumar.2008.628">Kumar et al [2008]</a> and <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al [2008]</a> both reported at least one instance of presumed germline mosaicism in a multiplex family in which sibs (who were not monozygous twins) both had the 16p11.2 recurrent microdeletion.</div></li><li class="half_rhythm"><div class="half_rhythm">The 16p11.2 recurrent microdeletion has not been reported to have a parent-of-origin bias.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to the sibs of a proband depends on the genetic status of the parents:</p><ul><li class="half_rhythm"><div>If the 16p11.2 recurrent microdeletion identified in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> is not identified in either parent, the empiric risk to sibs is approximately 1% because of the possibility of parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> for the microdeletion.</div></li><li class="half_rhythm"><div>If a parent also has the 16p11.2 recurrent microdeletion, the risk to each sib of inheriting the microdeletion is 50%. However, it is not possible to reliably predict the <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of the individual.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Offspring of an individual with the 16p11.2 recurrent microdeletion have a 50% chance of inheriting the microdeletion.</p><p><b>Other family members of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> The risk to other family members depends on the genetic status of the proband's parents: if a parent has the 16p11.2 recurrent microdeletion, his or her family members may also have the microdeletion.</p></div><div id="del16p11_2.Related_Genetic_Counseling_Is"><h3>Related Genetic Counseling Issues</h3><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. Similarly, decisions regarding testing to determine the genetic status of at-risk asymptomatic family members are best made before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are at risk of having a child with the 16p11.2 microdeletion.</div></li></ul><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="del16p11_2.Prenatal_Testing_and_Preimpla"><h3>Prenatal Testing and Preimplantation Genetic Testing</h3><p>Prenatal testing for pregnancies at increased risk for the 16p11.2 recurrent microdeletion is possible.</p><p>Note that counseling regarding the 16p11.2 recurrent microdeletion identified prenatally should take into account the clear <a class="def" href="/books/n/gene/glossary/def-item/genotype/">genotype</a>-<a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> correlation between cognitive disability and the microdeletion as well as the fact that the degree of cognitive disability is relative to the family background [<a class="bk_pop" href="#del16p11_2.REF.hanson.2015.785">Hanson et al 2015</a>].</p><p><b>Preimplantation genetic testing</b> may be an option for families in which the 16p11.2 recurrent microdeletion has been identified.</p></div></div><div id="del16p11_2.Resources"><h2 id="_del16p11_2_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>My46 Trait Profile</b></div><div><a href="https://www.my46.org/trait-document?trait=16p11.2%20microdeletion&#x00026;parent=Genetic%20Syndromes&#x00026;type=profile" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p11.2 microdeletion</a></div></li><li class="half_rhythm"><div><b>Chromosome Disorder Outreach (CDO)</b></div><div>PO Box 724</div><div>Boca Raton FL 33429-0724</div><div><b>Phone:</b> 561-395-4252 (Family Helpline)</div><div><b>Email:</b> info@chromodisorder.org</div><div><a href="http://www.chromodisorder.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.chromodisorder.org</a></div></li><li class="half_rhythm"><div><b>Unique: The Rare Chromosome Disorder Support Group</b></div><div>G1 The Stables</div><div>Station Road West</div><div>Oxted Surrey RH8 9EE</div><div>United Kingdom</div><div><b>Phone:</b> +44 (0) 1883 723356</div><div><b>Email:</b> info@rarechromo.org; rarechromo@aol.com</div><div><a href="http://www.rarechromo.org" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.rarechromo.org</a></div></li><li class="half_rhythm"><div><b>Simons VIP Connect Registry</b></div><div><i>An online community for individuals with genetic causes of autism. Simons VIP Connect is currently recruiting for a research study aimed to better understand the medical, cognitive and behavioral <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> of individuals with certain CNV's and genes related to autism.An online community for individuals with genetic causes of autism. Simons VIP Connect is currently recruiting for a research study aimed to better understand the medical, cognitive and behavioral phenotype of individuals with certain CNV's and genes related to autism.</i></div><div><a href="http://www.simonsvipconnect.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Simons VIP Connect</a></div></li></ul></div><div id="del16p11_2.Molecular_Genetics"><h2 id="_del16p11_2_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="del16p11_2.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>16p11.2 Recurrent Microdeletion: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11167/table/del16p11_2.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__del16p11_2.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_del16p11_2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Critical Region</th><th id="hd_b_del16p11_2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_del16p11_2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_del16p11_2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_del16p11_2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_del16p11_2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">AUTS14 </td><td headers="hd_b_del16p11_2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><i>Not applicable</i></td><td headers="hd_b_del16p11_2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">16p11.2</td><td headers="hd_b_del16p11_2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Not applicable</td><td headers="hd_b_del16p11_2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="del16p11_2.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="del16p11_2.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for 16p11.2 Recurrent Microdeletion (<a href="/omim/611913" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK11167/table/del16p11_2.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__del16p11_2.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/611913" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">611913</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">CHROMOSOME 16p11.2 DELETION SYNDROME, 593-KB</td></tr></tbody></table></div></div><div id="del16p11_2.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>16p11.2 microdeletion is mediated by <a class="def" href="/books/n/gene/glossary/def-item/nonallelic-homologous-recombination/">nonallelic homologous recombination</a> (NAHR) between flanking 147-kb low-copy repeat sequences with 99.5% sequence identity [<a class="bk_pop" href="#del16p11_2.REF.ghebranious.2007.1462">Ghebranious et al 2007</a>, <a class="bk_pop" href="#del16p11_2.REF.sebat.2007.445">Sebat et al 2007</a>, <a class="bk_pop" href="#del16p11_2.REF.kumar.2008.628">Kumar et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.marshall.2008.477">Marshall et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al 2008</a>]. The reciprocal <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> is also mediated by NAHR at the same site.</p><p><b>Genes typically included in this region.</b> The 16p11.2 recurrent microdeletion involves the loss of one chromosomal segment harboring 25 annotated genes or transcripts [<a class="bk_pop" href="#del16p11_2.REF.kumar.2008.628">Kumar et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.marshall.2008.477">Marshall et al 2008</a>, <a class="bk_pop" href="#del16p11_2.REF.weiss.2008.667">Weiss et al 2008</a>]. The <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> is flanked by segmental duplications that contain four additional genes.</p><p>How <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of these genes results in the clinical manifestations associated with the recurrent 16p11.2 deletion is largely unknown, but ongoing investigations have identified the roles of some key genes and their associated functional pathways as responsible for the phenotypic features.</p><p>While most of the genes at 16p11.2 exhibited dosage-dependent expression pattern [<a class="bk_pop" href="#del16p11_2.REF.migliavacca.2015.784">Migliavacca et al 2015</a>], the pathogenic functions of each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> or their combinations require further examination.</p><ul><li class="half_rhythm"><div><b><i>PRRT2</i></b>. Heterozygous <a class="def" href="/books/n/gene/glossary/def-item/loss-of-function/">loss-of-function</a> <i>PRRT2</i> pathogenic variants cause <a href="/books/n/gene/prrt2-parox/">autosomal dominant paroxysmal kinesigenic dyskinesia</a> as well as benign <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> infantile epilepsy and infantile convulsions with choreoathetosis syndrome [<a class="bk_pop" href="#del16p11_2.REF.heron.2012.152">Heron et al 2012</a>]. Both phenotypes have been reported in individuals with the 16p11.2 recurrent microdeletion.</div></li><li class="half_rhythm"><div><b><i>KCTD13</i></b><i>.</i> A smaller (~118-kb) <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> within 16p11.2 that segregated with ASD and other neurodevelopmental abnormalities has been identified [<a class="bk_pop" href="#del16p11_2.REF.crepel.2011.243">Crepel et al 2011</a>]. One of the five genes at this interval, <i>KCTD13</i>, was identified as a major driver for the neuroanatomic phenotypes of the 16p11.2 recurrent microdeletion [<a class="bk_pop" href="#del16p11_2.REF.golzio.2012.363">Golzio et al 2012</a>]. This <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> is associated with ciliary function, which is thought to be significantly disrupted in individuals with the 16p11.2 <a class="def" href="/books/n/gene/glossary/def-item/recurrent-deletion/">recurrent deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> [<a class="bk_pop" href="#del16p11_2.REF.migliavacca.2015.784">Migliavacca et al 2015</a>].</div></li><li class="half_rhythm"><div><b><i>TBX6.</i></b> It has been determined that vertebral abnormalities and scoliosis observed in some individuals with the 16p11.2 recurrent microdeletion result from a combination of a <a class="def" href="/books/n/gene/glossary/def-item/null/">null</a> <a class="def" href="/books/n/gene/glossary/def-item/allele/">allele</a> (i.e., the recurrent microdeletion) and a <a class="def" href="/books/n/gene/glossary/def-item/hypomorphic/">hypomorphic</a> allele [<a class="bk_pop" href="#del16p11_2.REF.wu.2015.341">Wu et al 2015</a>].</div></li></ul></div></div><div id="del16p11_2.References"><h2 id="_del16p11_2_References_">References</h2><div id="del16p11_2.Published_Guidelines__Consens"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 12-10-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF2">Autism and Developmental Disabilities Monitoring Network Surveillance Year 2006 Principal Investigators, Centers for Disease Control and Prevention. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006. Available <a href="http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5810a1.htm" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2009. Accessed 12-10-19. [<a href="/pubmed/20023608" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20023608</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF3">Council on Children with Disabilities, Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children with Special Needs Project Advisory Committee. Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. Available <a href="http://pediatrics.aappublications.org/content/118/1/405.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2006. Accessed 12-10-19. [<a href="/pubmed/16818591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16818591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.johnson.2007">Johnson CP, Myers SM, American Academy of Pediatrics Council on Children with Disabilities (2007) Identification and evaluation of children with autism spectrum disorders. Available <a href="http://pediatrics.aappublications.org/content/120/5/1183.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2007. Accessed 12-10-19. [<a href="/pubmed/17967920" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17967920</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.myers.2007">Myers SM, Johnson CP, American Academy of Pediatrics Council on Children with Disabilities. Management of children with autism spectrum disorders. Available <a href="http://pediatrics.aappublications.org/content/120/5/1162.long" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2007. Accessed 12-10-19. [<a href="/pubmed/17967921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17967921</span></a>]</div></li></ul></div><div id="del16p11_2.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.ballif.2007.1071">Ballif BC, Hornor SA, Jenkins E, Madan-Khetarpal S, Surti U, Jackson KE, Asamoah A, Brock PL, Gowans GC, Conway RL, Graham JM Jr, Medne L, Zackai EH, Shaikh TH, Geoghegan J, Selzer RR, Eis PS, Bejjani BA, Shaffer LG. Discovery of a previously unrecognized microdeletion syndrome of 16p11.2-p12.2. <span><span class="ref-journal">Nat Genet. </span>2007;<span class="ref-vol">39</span>:1071–3.</span> [<a href="/pubmed/17704777" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17704777</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.battaglia.2009.1200">Battaglia A, Novelli A, Bernardini L, Igliozzi R, Parrini B. Further characterization of the new microdeletion syndrome of 16p11.2-p12.2. <span><span class="ref-journal">Am J Med Genet A. </span>2009;<span class="ref-vol">149A</span>:1200–4.</span> [<a href="/pubmed/19449418" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19449418</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.bijlsma.2009.77">Bijlsma EK, Gijsbers AC, Schuurs-Hoeijmakers JH, van Haeringen A, Fransen van de Putte DE, Anderlid BM, Lundin J, Lapunzina P, P&#x000e9;rez Jurado LA, Delle Chiaie B, Loeys B, Menten B, Oostra A, Verhelst H, Amor DJ, Bruno DL, van Essen AJ, Hordijk R, Sikkema-Raddatz B, Verbruggen KT, Jongmans MC, Pfundt R, Reeser HM, Breuning MH, Ruivenkamp CA. Extending the phenotype of recurrent rearrangements of 16p11.2: deletions in mentally retarded patients without autism and in normal individuals. <span><span class="ref-journal">Eur J Med Genet. </span>2009;<span class="ref-vol">52</span>:77–87.</span> [<a href="/pubmed/19306953" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19306953</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.bochukova.2010.666">Bochukova EG, Huang N, Keogh J, Henning E, Purmann C, Blaszczyk K, Saeed S, Hamilton-Shield J, Clayton-Smith J, O'Rahilly S, Hurles ME, Farooqi IS. Large, rare chromosomal deletions associated with severe early-onset obesity. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">463</span>:666–70.</span> [<a href="/pmc/articles/PMC3108883/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3108883</span></a>] [<a href="/pubmed/19966786" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19966786</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.chen.2011.1252">Chen WJ, Lin Y, Xiong ZQ, Wei W, Ni W, Tan GH, Guo SL, He J, Chen YF, Zhang QJ, Li HF, Lin Y, Murong SX, Xu J, Wang N, Wu ZY. Exome sequencing identifies truncating mutations in PRRT2 that cause paroxysmal kinesigenic dyskinesia. <span><span class="ref-journal">Nat Genet. </span>2011;<span class="ref-vol">43</span>:1252–5.</span> [<a href="/pubmed/22101681" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22101681</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.council_on_children_with_disabilities.2006.405">Council on Children with Disabilities.  Section on Developmental Behavioral Pediatrics, Bright Futures Steering Committee, Medical Home Initiatives for Children with Special Needs Project Advisory Committee Identifying infants and young children with developmental disorders in the medical home: an algorithm for developmental surveillance and screening. <span><span class="ref-journal">Pediatrics. </span>2006;<span class="ref-vol">118</span>:405–20.</span> [<a href="/pubmed/16818591" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16818591</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.crepel.2011.243">Crepel A, Steyaert J, De la Marche W, De Wolf V, Fryns JP, Noens I, Devriendt K, Peeters H. Narrowing the critical deletion region for autism spectrum disorders on 16p11.2. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2011;<span class="ref-vol">156</span>:243–5.</span> [<a href="/pubmed/21302354" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21302354</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.fernandez.2010.195">Fernandez BA, Roberts W, Chung B, Weksberg R, Meyn S, Szatmari P, Joseph-George AM, Mackay S, Whitten K, Noble B, Vardy C, Crosbie V, Luscombe S, Tucker E, Turner L, Marshall CR, Scherer SW. Phenotypic spectrum associated with de novo and inherited deletions and duplications at 16p11.2 in individuals ascertained for diagnosis of autism spectrum disorder. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:195–203.</span> [<a href="/pubmed/19755429" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19755429</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.gault.2003.39">Gault J, Hopkins J, Berger R, Drebing C, Logel J, Walton C, Short M, Vianzon R, Olincy A, Ross RG, Adler LE, Freedman R, Leonard S. Comparison of polymorphisms in the alpha7 nicotinic receptor gene and its partial duplication in schizophrenic and control subjects. <span><span class="ref-journal">Am J Med Genet B Neuropsychiatr Genet. </span>2003;<span class="ref-vol">123B</span>:39–49.</span> [<a href="/pubmed/14582144" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14582144</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.ghebranious.2007.1462">Ghebranious N, Giampietro PF, Wesbrook FP, Rezkalla SH. A novel microdeletion at 16p11.2 harbors candidate genes for aortic valve development, seizure disorder, and mild mental retardation. <span><span class="ref-journal">Am J Med Genet A. </span>2007;<span class="ref-vol">143A</span>:1462–71.</span> [<a href="/pubmed/17568417" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17568417</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.gill.2014.2625">Gill R, Chen Q, D'Angelo D, Chung WK. Eating in the absence of hunger but not loss of control behaviors are associated with 16p11.2 deletions. <span><span class="ref-journal">Obesity (Silver Spring). </span>2014;<span class="ref-vol">22</span>:2625–31.</span> [<a href="/pubmed/25234362" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25234362</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.golzio.2012.363">Golzio C, Willer J, Talkowski ME, Oh EC, Taniguchi Y, Jacquemont S, Reymond A, Sun M, Sawa A, Gusella JF, Kamiya A, Beckmann JS, Katsanis N. KCTD13 is a major driver of mirrored neuroanatomical phenotypes of the 16p11.2 copy number variant. <span><span class="ref-journal">Nature. </span>2012;<span class="ref-vol">485</span>:363–7.</span> [<a href="/pmc/articles/PMC3366115/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3366115</span></a>] [<a href="/pubmed/22596160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22596160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.hanson.2015.785">Hanson E, Bernier R, Porche K, Jackson FI, Goin-Kochel RP, Snyder LG, Snow AV, Wallace AS, Campe KL, Zhang Y, Chen Q, D'Angelo D, Moreno-De-Luca A, Orr PT, Boomer KB, Evans DW, Kanne S, Berry L, Miller FK, Olson J, Sherr E, Martin CL, Ledbetter DH, Spiro JE, Chung WK, et al.  The cognitive and behavioral phenotype of the 16p11.2 deletion in a clinically ascertained population. <span><span class="ref-journal">Biol Psychiatry. </span>2015;<span class="ref-vol">77</span>:785–93.</span> [<a href="/pmc/articles/PMC5410712/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC5410712</span></a>] [<a href="/pubmed/25064419" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25064419</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.hanson.2010.649">Hanson E, Nasir RH, Fong A, Lian A, Hundley R, Shen Y, Wu BL, Holm IA, Miller DT, et al.  Cognitive and behavioral characterization of 16p11.2 deletion syndrome. <span><span class="ref-journal">J Dev Behav Pediatr. </span>2010;<span class="ref-vol">31</span>:649–57.</span> [<a href="/pubmed/20613623" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20613623</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.heron.2012.152">Heron SE, Grinton BE, Kivity S, Afawi Z, Zuberi SM, Hughes JN, Pridmore C, Hodgson BL, Iona X, Sadleir LG, Pelekanos J, Herlenius E, Goldberg-Stern H, Bassan H, Haan E, Korczyn AD, Gardner AE, Corbett MA, G&#x000e9;cz J, Thomas PQ, Mulley JC, Berkovic SF, Scheffer IE, Dibbens LM. PRRT2 mutations cause benign familial infantile epilepsy and infantile convulsions with choreoathetosis syndrome. <span><span class="ref-journal">Am J Hum Genet. </span>2012;<span class="ref-vol">90</span>:152–60.</span> [<a href="/pmc/articles/PMC3257886/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3257886</span></a>] [<a href="/pubmed/22243967" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22243967</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.jacquemont.2011.97">Jacquemont S, Reymond A, Zufferey F, Harewood L, Walters RG, Kutalik Z, Martinet D, Shen Y, Valsesia A, Beckmann ND, Thorleifsson G, Belfiore M, Bouquillon S, Campion D, de Leeuw N, de Vries BB, Esko T, Fernandez BA, Fern&#x000e1;ndez-Aranda F, Fern&#x000e1;ndez-Real JM, Gratac&#x000f2;s M, Guilmatre A, Hoyer J, Jarvelin MR, Kooy RF, Kurg A, Le Caignec C, M&#x000e4;nnik K, Platt OS, Sanlaville D, Van Haelst MM, Villatoro Gomez S, Walha F, Wu BL, Yu Y, Aboura A, Addor MC, Alembik Y, Antonarakis SE, Arveiler B, Barth M, Bednarek N, B&#x000e9;na F, Bergmann S, Beri M, Bernardini L, Blaumeiser B, Bonneau D, Bottani A, Boute O, Brunner HG, Cailley D, Callier P, Chiesa J, Chrast J, Coin L, Coutton C, Cuisset JM, Cuvellier JC, David A, de Freminville B, Delobel B, Delrue MA, Demeer B, Descamps D, Didelot G, Dieterich K, Disciglio V, Doco-Fenzy M, Drunat S, Duban-Bedu B, Dubourg C, El-Sayed Moustafa JS, Elliott P, Faas BH, Faivre L, Faudet A, Fellmann F, Ferrarini A, Fisher R, Flori E, Forer L, Gaillard D, Gerard M, Gieger C, Gimelli S, Gimelli G, Grabe HJ, Guichet A, Guillin O, Hartikainen AL, Heron D, Hippolyte L, Holder M, Homuth G, Isidor B, Jaillard S, Jaros Z, Jim&#x000e9;nez-Murcia S, Helas GJ, Jonveaux P, Kaksonen S, Keren B, Kloss-Brandst&#x000e4;tter A, Knoers NV, Koolen DA, Kroisel PM, Kronenberg F, Labalme A, Landais E, Lapi E, Layet V, Legallic S, Leheup B, Leube B, Lewis S, Lucas J, MacDermot KD, Magnusson P, Marshall C, Mathieu-Dramard M, McCarthy MI, Meitinger T, Mencarelli MA, Merla G, Moerman A, Mooser V, Morice-Picard F, Mucciolo M, Nauck M, Ndiaye NC, Nordgren A, Pasquier L, Petit F, Pfundt R, Plessis G, Rajcan-Separovic E, Ramelli GP, Rauch A, Ravazzolo R, Reis A, Renieri A, Richart C, Ried JS, Rieubland C, Roberts W, Roetzer KM, Rooryck C, Rossi M, Saemundsen E, Satre V, Schurmann C, Sigurdsson E, Stavropoulos DJ, Stefansson H, Tengstr&#x000f6;m C, Thorsteinsd&#x000f3;ttir U, Tinahones FJ, Touraine R, Vall&#x000e9;e L, van Binsbergen E, Van der Aa N, Vincent-Delorme C, Visvikis-Siest S, Vollenweider P, V&#x000f6;lzke H, Vulto-van Silfhout AT, Waeber G, Wallgren-Pettersson C, Witwicki RM, Zwolinksi S, Andrieux J, Estivill X, Gusella JF, Gustafsson O, Metspalu A, Scherer SW, Stefansson K, Blakemore AI, Beckmann JS, Froguel P. Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. <span><span class="ref-journal">Nature. </span>2011;<span class="ref-vol">478</span>:97–102.</span> [<a href="/pmc/articles/PMC3637175/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3637175</span></a>] [<a href="/pubmed/21881559" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21881559</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.johnson.2007.1183">Johnson CP, Myers SM, et al.  Identification and evaluation of children with autism spectrum disorders. <span><span class="ref-journal">Pediatrics. </span>2007;<span class="ref-vol">120</span>:1183–215.</span> [<a href="/pubmed/17967920" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17967920</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.kaminsky.2011.777">Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-De-Luca D, Moreno-De-Luca A, Mulle JG, Warren ST, Richard G, Compton JG, Fuller AE, Gliem TJ, Huang S, Collinson MN, Beal SJ, Ackley T, Pickering DL, Golden DM, Aston E, Whitby H, Shetty S, Rossi MR, Rudd MK, South ST, Brothman AR, Sanger WG, Iyer RK, Crolla JA, Thorland EC, Aradhya S, Ledbetter DH, Martin CL. An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities. <span><span class="ref-journal">Genet Med. </span>2011;2011;<span class="ref-vol">13</span>:777–84.</span> [<a href="/pmc/articles/PMC3661946/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3661946</span></a>] [<a href="/pubmed/21844811" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21844811</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.kumar.2008.628">Kumar RA, Karamohamed S, Sudi J, Conrad DF, Brune C, Badner JA, Gilliam TC, Nowak NJ, Cook EH Jr, Dobyns WB, Christian SL. Recurrent 16p11.2 microdeletions in autism. <span><span class="ref-journal">Hum Mol Genet. </span>2008;<span class="ref-vol">17</span>:628–38.</span> [<a href="/pubmed/18156158" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18156158</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.lee.2012.2">Lee HY, Huang Y, Bruneau N, Roll P, Roberson ED, Hermann M, Quinn E, Maas J, Edwards R, Ashizawa T, Baykan B, Bhatia K, Bressman S, Bruno MK, Brunt ER, Caraballo R, Echenne B, Fejerman N, Frucht S, Gurnett CA, Hirsch E, Houlden H, Jankovic J, Lee WL, Lynch DR, Mohammed S, M&#x000fc;ller U, Nespeca MP, Renner D, Rochette J, Rudolf G, Saiki S, Soong BW, Swoboda KJ, Tucker S, Wood N, Hanna M, Bowcock AM, Szepetowski P, Fu YH, Pt&#x000e1;&#x0010d;ek LJ. Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. <span><span class="ref-journal">Cell Rep. </span>2012;<span class="ref-vol">1</span>:2–12.</span> [<a href="/pmc/articles/PMC3334308/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3334308</span></a>] [<a href="/pubmed/22832103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22832103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.li.2012.76">Li J, Zhu X, Wang X, Sun W, Feng B, Du T, Sun B, Niu F, Wei H, Wu X, Dong L, Li L, Cai X, Wang Y, Liu Y. Targeted genomic sequencing identifies PRRT2 mutations as a cause of paroxysmal kinesigenic choreoathetosis. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:76–8.</span> [<a href="/pmc/articles/PMC3261727/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3261727</span></a>] [<a href="/pubmed/22131361" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22131361</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.marshall.2008.477">Marshall CR, Noor A, Vincent JB, Lionel AC, Feuk L, Skaug J, Shago M, Moessner R, Pinto D, Ren Y, Thiruvahindrapduram B, Fiebig A, Schreiber S, Friedman J, Ketelaars CE, Vos YJ, Ficicioglu C, Kirkpatrick S, Nicolson R, Sloman L, Summers A, Gibbons CA, Teebi A, Chitayat D, Weksberg R, Thompson A, Vardy C, Crosbie V, Luscombe S, Baatjes R, Zwaigenbaum L, Roberts W, Fernandez B, Szatmari P, Scherer SW. Structural variation of chromosomes in autism spectrum disorder. <span><span class="ref-journal">Am J Hum Genet. </span>2008;<span class="ref-vol">82</span>:477–88.</span> [<a href="/pmc/articles/PMC2426913/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2426913</span></a>] [<a href="/pubmed/18252227" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18252227</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.mccarthy.2009.1223">McCarthy SE, Makarov V, Kirov G, Addington AM, McClellan J, Yoon S, Perkins DO, Dickel DE, Kusenda M, Krastoshevsky O, Krause V, Kumar RA, Grozeva D, Malhotra D, Walsh T, Zackai EH, Kaplan P, Ganesh J, Krantz ID, Spinner NB, Roccanova P, Bhandari A, Pavon K, Lakshmi B, Leotta A, Kendall J, Lee YH, Vacic V, Gary S, Iakoucheva LM, Crow TJ, Christian SL, Lieberman JA, Stroup TS, Lehtim&#x000e4;ki T, Puura K, Haldeman-Englert C, Pearl J, Goodell M, Willour VL, Derosse P, Steele J, Kassem L, Wolff J, Chitkara N, McMahon FJ, Malhotra AK, Potash JB, Schulze TG, N&#x000f6;then MM, Cichon S, Rietschel M, Leibenluft E, Kustanovich V, Lajonchere CM, Sutcliffe JS, Skuse D, Gill M, Gallagher L, Mendell NR, Craddock N, Owen MJ, O'Donovan MC, Shaikh TH, Susser E, Delisi LE, Sullivan PF, Deutsch CK, Rapoport J, Levy DL, King MC, Sebat J, et al.  Microduplications of 16p11.2 are associated with schizophrenia. <span><span class="ref-journal">Nat Genet. </span>2009;<span class="ref-vol">41</span>:1223–7.</span> [<a href="/pmc/articles/PMC2951180/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2951180</span></a>] [<a href="/pubmed/19855392" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19855392</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.mefford.2009.1579">Mefford HC, Cooper GM, Zerr T, Smith JD, Baker C, Shafer N, Thorland EC, Skinner C, Schwartz CE, Nickerson DA, Eichler EE. A method for rapid, targeted CNV genotyping identifies rare variants associated with neurocognitive disease. <span><span class="ref-journal">Genome Res. </span>2009;<span class="ref-vol">19</span>:1579–85.</span> [<a href="/pmc/articles/PMC2752120/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2752120</span></a>] [<a href="/pubmed/19506092" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19506092</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.migliavacca.2015.784">Migliavacca E, Golzio C, M&#x000e4;nnik K, Blumenthal I, Oh EC, Harewood L, Kosmicki JA, Loviglio MN, Giannuzzi G, Hippolyte L, Maillard AM, Alfaiz AA, van Haelst MM, Andrieux J, Gusella JF, Daly MJ, Beckmann JS, Jacquemont S, Talkowski ME, Katsanis N, Reymond A, et al.  A potential contributory role for ciliary dysfunction in the 16p11.2 600 kb BP4-BP5 pathology. <span><span class="ref-journal">Am J Hum Genet. </span>2015;<span class="ref-vol">96</span>:784–96.</span> [<a href="/pmc/articles/PMC4570289/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4570289</span></a>] [<a href="/pubmed/25937446" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25937446</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.morenodeluca.2015.119">Moreno-De-Luca A, Evans DW, Boomer KB, Hanson E, Bernier R, Goin-Kochel RP, Myers SM, Challman TD, Moreno-De-Luca D, Slane MM, Hare AE, Chung WK, Spiro JE, Faucett WA, Martin CL, Ledbetter DH. The role of parental cognitive, behavioral, and motor profiles in clinical variability in individuals with chromosome 16p11.2 deletions. <span><span class="ref-journal">JAMA Psychiatry. </span>2015;<span class="ref-vol">72</span>:119–26.</span> [<a href="/pubmed/25493922" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25493922</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.myers.2007.1162">Myers SM, Johnson CP, et al.  Management of children with autism spectrum disorders. <span><span class="ref-journal">Pediatrics. </span>2007;<span class="ref-vol">120</span>:1162–82.</span> [<a href="/pubmed/17967921" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17967921</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.qureshi.2014.11199">Qureshi AY, Mueller S, Snyder AZ, Mukherjee P, Berman JI, Roberts TP, Nagarajan SS, Spiro JE, Chung WK, Sherr EH, Buckner RL. Opposing brain differences in 16p11.2 deletion and duplication carriers. <span><span class="ref-journal">J Neurosci. </span>2014;<span class="ref-vol">34</span>:11199–211.</span> [<a href="/pmc/articles/PMC4138332/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4138332</span></a>] [<a href="/pubmed/25143601" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25143601</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.rosenfeld.2010.26">Rosenfeld JA, Coppinger J, Bejjani BA, Girirajan S, Eichler EE, Shaffer LG, Ballif BC. Speech delays and behavioral problems are the predominant features in individuals with developmental delays and 16p11.2 microdeletions and microduplications. <span><span class="ref-journal">J Neurodev Disord. </span>2010;<span class="ref-vol">2</span>:26–38.</span> [<a href="/pmc/articles/PMC3125720/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3125720</span></a>] [<a href="/pubmed/21731881" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21731881</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.schaaf.2011.152">Schaaf CP, Goin-Kochel RP, Nowell KP, Hunter JV, Aleck KA, Cox S, Patel A, Bacino CA, Shinawi M. Expanding the clinical spectrum of the 16p11.2 chromosomal rearrangements: three patients with syringomyelia. <span><span class="ref-journal">Eur J Hum Genet. </span>2011;<span class="ref-vol">19</span>:152–6.</span> [<a href="/pmc/articles/PMC3025795/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3025795</span></a>] [<a href="/pubmed/20959866" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20959866</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.sebat.2007.445">Sebat J, Lakshmi B, Malhotra D, Troge J, Lese-Martin C, Walsh T, Yamrom B, Yoon S, Krasnitz A, Kendall J, Leotta A, Pai D, Zhang R, Lee YH, Hicks J, Spence SJ, Lee AT, Puura K, Lehtim&#x000e4;ki T, Ledbetter D, Gregersen PK, Bregman J, Sutcliffe JS, Jobanputra V, Chung W, Warburton D, King MC, Skuse D, Geschwind DH, Gilliam TC, Ye K, Wigler M. Strong association of de novo copy number mutations with autism. <span><span class="ref-journal">Science. </span>2007;<span class="ref-vol">316</span>:445–9.</span> [<a href="/pmc/articles/PMC2993504/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2993504</span></a>] [<a href="/pubmed/17363630" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17363630</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.shinawi.2010.332">Shinawi M, Liu P, Kang SH, Shen J, Belmont JW, Scott DA, Probst FJ, Craigen WJ, Graham BH, Pursley A, Clark G, Lee J, Proud M, Stocco A, Rodriguez DL, Kozel BA, Sparagana S, Roeder ER, McGrew SG, Kurczynski TW, Allison LJ, Amato S, Savage S, Patel A, Stankiewicz P, Beaudet AL, Cheung SW, Lupski JR. Recurrent reciprocal 16p11.2 rearrangements associated with global developmental delay, behavioural problems, dysmorphism, epilepsy, and abnormal head size. <span><span class="ref-journal">J Med Genet. </span>2010;<span class="ref-vol">47</span>:332–41.</span> [<a href="/pmc/articles/PMC3158566/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3158566</span></a>] [<a href="/pubmed/19914906" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19914906</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.shiow.2009.24">Shiow LR, Paris K, Akana MC, Cyster JG, Sorensen RU, Puck JM. Severe combined immunodeficiency (SCID) and attention deficit hyperactivity disorder (ADHD) associated with a Coronin-1A mutation and a chromosome 16p11.2 deletion. <span><span class="ref-journal">Clin Immunol. </span>2009;<span class="ref-vol">131</span>:24–30.</span> [<a href="/pmc/articles/PMC2692687/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2692687</span></a>] [<a href="/pubmed/19097825" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19097825</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.stefansson.2014.361">Stefansson H, Meyer-Lindenberg A, Steinberg S, et al.  CNVs conferring risk of autism or schizophrenia affect cognition in controls. <span><span class="ref-journal">Nature. </span>2014;<span class="ref-vol">505</span>:361–6.</span> [<a href="/pubmed/24352232" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 24352232</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.termsarasab.2014.274">Termsarasab P, Yang AC, Reiner J, Mei H, Scott SA, Frucht SJ. Paroxysmal kinesigenic dyskinesia caused by 16p11.2 microdeletion. <span><span class="ref-journal">Tremor Other Hyperkinet Mov (N Y). </span>2014;<span class="ref-vol">4</span>:274.</span> [<a href="/pmc/articles/PMC4303604/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4303604</span></a>] [<a href="/pubmed/25667815" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25667815</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.walsh.2008.539">Walsh T, McClellan JM, McCarthy SE, Addington AM, Pierce SB, Cooper GM, Nord AS, Kusenda M, Malhotra D, Bhandari A, Stray SM, Rippey CF, Roccanova P, Makarov V, Lakshmi B, Findling RL, Sikich L, Stromberg T, Merriman B, Gogtay N, Butler P, Eckstrand K, Noory L, Gochman P, Long R, Chen Z, Davis S, Baker C, Eichler EE, Meltzer PS, Nelson SF, Singleton AB, Lee MK, Rapoport JL, King MC, Sebat J. Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia. <span><span class="ref-journal">Science. </span>2008;<span class="ref-vol">320</span>:539–43.</span> [<a href="/pubmed/18369103" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18369103</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.walters.2010.671">Walters RG, Jacquemont S, Valsesia A, de Smith AJ, Martinet D, Andersson J, Falchi M, Chen F, Andrieux J, Lobbens S, Delobel B, Stutzmann F, El-Sayed Moustafa JS, Ch&#x000e8;vre JC, Lecoeur C, Vatin V, Bouquillon S, Buxton JL, Boute O, Holder-Espinasse M, Cuisset JM, Lemaitre MP, Ambresin AE, Brioschi A, Gaillard M, Giusti V, Fellmann F, Ferrarini A, Hadjikhani N, Campion D, Guilmatre A, Goldenberg A, Calmels N, Mandel JL, Le Caignec C, David A, Isidor B, Cordier MP, Dupuis-Girod S, Labalme A, Sanlaville D, B&#x000e9;ri-Dexheimer M, Jonveaux P, Leheup B, Ounap K, Bochukova EG, Henning E, Keogh J, Ellis RJ, Macdermot KD, van Haelst MM, Vincent-Delorme C, Plessis G, Touraine R, Philippe A, Malan V, Mathieu-Dramard M, Chiesa J, Blaumeiser B, Kooy RF, Caiazzo R, Pigeyre M, Balkau B, Sladek R, Bergmann S, Mooser V, Waterworth D, Reymond A, Vollenweider P, Waeber G, Kurg A, Palta P, Esko T, Metspalu A, Nelis M, Elliott P, Hartikainen AL, McCarthy MI, Peltonen L, Carlsson L, Jacobson P, Sj&#x000f6;str&#x000f6;m L, Huang N, Hurles ME, O'Rahilly S, Farooqi IS, M&#x000e4;nnik K, Jarvelin MR, Pattou F, Meyre D, Walley AJ, Coin LJ, Blakemore AI, Froguel P, Beckmann JS. A new highly penetrant form of obesity due to deletions on chromosome 16p11.2. <span><span class="ref-journal">Nature. </span>2010;<span class="ref-vol">463</span>:671–5.</span> [<a href="/pmc/articles/PMC2880448/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2880448</span></a>] [<a href="/pubmed/20130649" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20130649</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.wang.2011.3493">Wang JL, Cao L, Li XH, Hu ZM, Li JD, Zhang JG, Liang Y. San-A, Li N, Chen SQ, Guo JF, Jiang H, Shen L, Zheng L, Mao X, Yan WQ, Zhou Y, Shi YT, Ai SX, Dai MZ, Zhang P, Xia K, Chen SD, Tang BS. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. <span><span class="ref-journal">Brain. </span>2011;<span class="ref-vol">134</span>:3493–501.</span> [<a href="/pmc/articles/PMC3235563/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3235563</span></a>] [<a href="/pubmed/22120146" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22120146</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.weiss.2008.667">Weiss LA, Shen Y, Korn JM, Arking DE, Miller DT, Fossdal R, Saemundsen E, Stefansson H, Ferreira MA, Green T, Platt OS, Ruderfer DM, Walsh CA, Altshuler D, Chakravarti A, Tanzi RE, Stefansson K, Santangelo SL, Gusella JF, Sklar P, Wu BL, Daly MJ, et al.  Association between microdeletion and microduplication at 16p11.2 and autism. <span><span class="ref-journal">N Engl J Med. </span>2008;<span class="ref-vol">358</span>:667–75.</span> [<a href="/pubmed/18184952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 18184952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.wu.2015.341">Wu N, Ming X, Xiao J, Wu Z, Chen X, Shinawi M, Shen Y, Yu G, Liu J, Xie H, Gucev ZS, Liu S, Yang N, Al-Kateb H, Chen J, Zhang J, Hauser N, Zhang T, Tasic V, Liu P, Su X, Pan X, Liu C, Wang L, Shen J, Shen J, Chen Y, Zhang T, Zhang J, Choy KW, Wang J, Wang Q, Li S, Zhou W, Guo J, Wang Y, Zhang C, Zhao H, An Y, Zhao Y, Wang J, Liu Z, Zuo Y, Tian Y, Weng X, Sutton VR, Wang H, Ming Y, Kulkarni S, Zhong TP, Giampietro PF, Dunwoodie SL, Cheung SW, Zhang X, Jin L, Lupski JR, Qiu G, Zhang F. TBX6 null variants and a common hypomorphic allele in congenital scoliosis. <span><span class="ref-journal">N Engl J Med. </span>2015;<span class="ref-vol">372</span>:341–50.</span> [<a href="/pmc/articles/PMC4326244/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4326244</span></a>] [<a href="/pubmed/25564734" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25564734</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="del16p11_2.REF.zufferey.2012.660">Zufferey F, Sherr EH, Beckmann ND, Hanson E, Maillard AM, Hippolyte L, Mac&#x000e9; A, Ferrari C, Kutalik Z, Andrieux J, Aylward E, Barker M, Bernier R, Bouquillon S, Conus P, Delobel B, Faucett WA, Goin-Kochel RP, Grant E, Harewood L, Hunter JV, Lebon S, Ledbetter DH, Martin CL, Mannik K, Martinet D, Mukherjee P, Ramocki MB, Spence SJ, Steinman K, Tjernagel J, Spiro JE, Reymond A, Beckmann JS, Chung WK, Jacquemont S, et al.  A 600 kb deletion syndrome at 16p11.2 leads to energy imbalance and neuropsychiatric disorders. <span><span class="ref-journal">J Med Genet. </span>2012;<span class="ref-vol">49</span>:660–8.</span> [<a href="/pmc/articles/PMC3494011/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3494011</span></a>] [<a href="/pubmed/23054248" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23054248</span></a>]</div></li></ul></div></div><div id="del16p11_2.Chapter_Notes"><h2 id="_del16p11_2_Chapter_Notes_">Chapter Notes</h2><div id="del16p11_2.Author_Notes"><h3>Author Notes</h3><p>Drs Miller, Shen, and Wu are all consultants to a genetic testing lab that performs aCGH testing.</p></div><div id="del16p11_2.Author_History"><h3>Author History</h3><p>Wendy Chung, MD, PhD, FACMG (2015-present)<br />Ellen Hanson, PhD (2009-present)<br />Rachel Hundley, PhD; Boston Children's Hospital (2009-2011)<br />David T Miller, MD, PhD, FACMG (2009-present)<br />Ramzi Nasir, MD, MPH (2009-present)<br />Yiping Shen, PhD, FACMG (2009-present)<br />Magdi M Sobeih, MD, PhD; Boston Children's Hospital (2009-2015)<br />Kyle J Steinman, MD, MAS (2015-present)<br />Bai-Lin Wu, MMed, PhD, FACMG (2009-present)</p></div><div id="del16p11_2.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>10 December 2015 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>27 October 2011 (dtm) Revision: author addition to Evaluations Following Initial Diagnosis</div></li><li class="half_rhythm"><div>8 February 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>22 September 2009 (et) Review posted live</div></li><li class="half_rhythm"><div>6 March 2009 (dtm) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK11167</span><span class="label">PMID: <a href="/pubmed/20301775" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301775</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/mdel15q24/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/mdel16p12_2/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK11167&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK11167/?report=reader">PubReader</a></li><li><a href="/books/NBK11167/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK11167" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK11167" style="display:none" title="Cite this Page"><div class="bk_tt">Miller DT, Chung W, Nasir R, et al. 16p11.2 Recurrent Microdeletion. 2009 Sep 22 [Updated 2015 Dec 10]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK11167/pdf/Bookshelf_NBK11167.pdf">PDF version of this page</a> (209K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#del16p11_2.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#del16p11_2.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#del16p11_2.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#del16p11_2.Genetically_Related_Allelic_D" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#del16p11_2.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#del16p11_2.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#del16p11_2.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#del16p11_2.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#del16p11_2.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#del16p11_2.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#del16p11_2.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Variations in ClinVar</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=NBK11167+AND+genereviews[submitter]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Variations from this GeneReview in ClinVar</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1617178" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1617178" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1617178" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301696" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 22q11.2 Deletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">McDonald-McGinn DM, Emanuel BS, Zackai EH. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21290787" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 15q13.3 Microdeletion</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 15q13.3 Microdeletion<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">van Bon BWM, Mefford HC, de Vries BBA. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/20301337" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 2q37 Microdeletion Syndrome</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 2q37 Microdeletion Syndrome<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Doherty ES, Lacbawan FL. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/26925472" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 17q12 Recurrent Duplication</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 17q12 Recurrent Duplication<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Mefford H, Mitchell E, Hodge J. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21348049" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 1q21.1 Recurrent Microdeletion</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> 1q21.1 Recurrent Microdeletion<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Haldeman-Englert CR, Jewett T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301775" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301775" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e041aaadde089116968acd9">16p11.2 Recurrent Microdeletion - GeneReviews®</a><div class="ralinkpop offscreen_noflow">16p11.2 Recurrent Microdeletion - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T21:27:54-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal105&amp;ncbi_phid=CE8CFC03E04138910000000002FD010D&amp;ncbi_session=CE8CFC03E041AA91_0765SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK11167%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK11167&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK11167/&amp;ncbi_pagename=16p11.2 Recurrent Microdeletion - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8CFC03E041AA91_0765SID /projects/books/PBooks@5.22 portal105 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>